Ratan Tata invests in Generic Aadhaar to bring affordable medicines to masses

MUMBAI: Ratan Tata, on Thursday, invested an undisclosed quantity in pharmaceutical enterprise Generic Aadhaar. Founded by Arjun Deshpande, the startup claims to have an annual income of Rs 6 crore and is taking a look at a income of Rs 150-200 crore in the subsequent three years.
Generic Aadhaar follows a pharmacy-aggregator enterprise mannequin sourcing generic medication immediately from the producer and offering it to the retailers, thereby reducing out the middlemen fully and delivering medicines to masses at a a lot lesser price. It is a B2B2C mannequin that goals at offering Indians with affordable medicine by supporting single medical shops throughout the nation which in any other case face competitors from large manufacturers and on-line pharmacies. Under Generic Aadhaar, the corporate gives medicine immediately from WHO-GMP facility and has tied up with 30 retailers from Mumbai, Pune, Bangalore and Odisha following a profit-sharing mannequin.

Deshpande, mentioned in a press release, “Our mission is to provide senior citizens and pension holders the care they deserve with our idea of delivering inexpensive medicines which are required on a daily basis.”

A survey states that 60% of Indians can not afford correct medicine due to their excessive market value and therefore fall behind to ship primary healthcare wants to individuals. Generic Aadhaar goals to associate with 1000 pharmacies on a franchisee-based mannequin in the approaching months and increase their attain to markets like to Gujarat, Tamil Nadu, Andhra Pradesh, New Delhi, Goa, Rajasthan, Gujarat.

Leave a Reply

%d bloggers like this: